| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500290 | Farmacia Hospitalaria | 2010 | 7 Pages |
Abstract
Prophylactic treatment with palifermin reduces the duration of oral mucosities in patients with haematological cancer. Further studies are necessary with larger samples to be able to assess palifermin and its influence on other variables, such as incidence of mucositis, sepsis, febrile neutropenia, etc.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
D. Ayago Flores, R. Ferriols Lisart,